The safety of live attenuated influenza vaccine in children and adolescents 2 through 17  years of age: A Vaccine Safety Datalink study

ConclusionsIn a study of trivalent LAIV safety in a large cohort of children, few serious adverse events were detected. Anaphylaxis and syncope occurred following LAIV, although rarely. These data provide reassurance regarding continued LAIV use.

Source: Pharmacoepidemiology and Drug Safety - November 17, 2017 Category: Drugs & Pharmacology Authors: Matthew F. Daley, Christina L. Clarke, Jason M. Glanz, Stanley Xu, Simon J. Hambidge, James G. Donahue, James D. Nordin, Nicola P. Klein, Steven J. Jacobsen, Allison L. Naleway, Michael L. Jackson, Grace Lee, Jonathan Duffy, Eric Weintraub Tags: ORIGINAL REPORT Source Type: research